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Abstract
Amyloid Beta (Aβ) was the major focus of this study. It is a peptide that is present in the
brain with a high tendency to self-aggregate. When this protein aggregates, it forms oligomers
and protofibrils which in turn are deposited as senile plaques in the brain. The reason for the
concern with these plaques is their association with the neurological disorder Alzheimer’s
disease. It has been found that the most dangerous oligomers are formed in a portion of the
plasma membrane known as lipid rafts. The purpose of this study was to understand how
micelles affect the aggregation properties of Aβ. To model the lipid rafts in the brain, micelles
formed from DHPC and DMPC were used. Aβ and these micelles were separated using
micellular electrokinetic chromatography (MEKC). It was determined that micelles in sodium
phosphate buffer could successfully be detected by MEKC. With the success of further
experimentation, more will be known about the way that the lipids rafts in the brain affect the
aggregation of micelles. This knowledge could one day help in the prevention of the onset of
Alzheimer’s disease.

Introduction
With the human life expectancy around the world progressively getting longer with each
generation, dementia is a problem that has become increasingly frequent. Dementia itself is not a
specific disease, rather a general term used to describe a decline in mental abilities. Alzheimer’s
disease (AD) is the most common form of dementia, accounting for around 70 percent of all
diagnosed patients. AD is a neurodegenerative disorder affecting around 1 in 3 people over 80
years old in the US. In 2010, it was estimated that the global cost of AD is upwards of $600
billion [1]. This disease is characterized by serious loss of memory, confusion, disorientation,
and in severe cases, loss of motor function. Unfortunately to date, there is no cure for this deadly
disease
AD has been strongly linked to the presence of extracellular senile plaques in the brain.
Amyloid-β (Aβ) peptides, derived from proteolytic processing of the amyloid precursor protein
(APP), are known to be one of the major constituents of these senile plaques [1]. Aβ is a protein
found in the brain and cerebrospinal fluid of healthy and diseased individuals alike [1]. These
peptides have a strong affinity for each other and a high tendency to aggregate. As the peptides
aggregate, they form a mixture of oligomers and protofibrils that eventually are deposited as
fibrils in senile plaques [1]. In recent studies, it has been found that these protofibrils have
increased neurotoxicity upon being fragmented [2]. It was found that Aβ oligomers created by
fragmentation from protofibrils actually have a higher correlation with AD than plaques or fibrils
[2]. The oligomers have a preferential binding toward the neurons in the hippocampus,
explaining why they may be prone to cause AD [2]. It was also found that neuronal receptors that
bind to the Aβ plaques and their fragmented oligomers have been identified to primarily reside in
lipid rafts. Lipid rafts are cholesterol rich microdomains within the plasma membrane of cells. In
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order for senile plaque formation to onset AD, Aβ must be formed, assembled into oligomers,
and these oligomers must interact with neuronal receptors. As science searches for therapeutic
interventions, these three pathways are potential sites of modification in hope of preventing the
onset of AD [1].
Lipid Rafts and Amyloid β
Lipid rafts are floating microdomains within the plasma membrane with distinct lipid
composition, mainly of cholesterol and sphingolipids [1]. They have been identified to play a
crucial role in the formation of Aβ and their oligomer byproducts. Lipids rafts help to
compartmentalize cellular process by bringing together specific lipids and proteins. They are also
critical in regulating the assembly of signaling and trafficking molecules essential for neural
development [1]. Furthermore, these rafts are necessary for dendritic spine and synapse
maintenance that are involved in two major processes that are lost in AD: learning and memory
[3].
Lipid rafts play a vital role in regulating the APP to Aβ amyloidogenic processing. While
a majority of APP is cleaved in non-raft portions of the plasma membrane, it is the cleavage that
takes place in the lipid rafts that is a cause for concern. Within the rafts, the APP cleavage is
initiated by the β-site APP cleaving enzyme-1 (BACE1) [1]. Upon cleaving, the intact Aβ
sequence is left behind anchored by the C-terminal fragment. A second cleaving process is
completed by γ-secretase complex that releases Aβ peptides of between 39-42 residues in length.
It has been recently identified that there is a direct interaction between APP and cholesterol.
High concentrations of cholesterol have been linked to an increase of APP, BACE1 and γsecretase components in lipid rafts. Along with increases of cholesterol and ganglioside GM1,
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these components together in a lipid raft have been found to promote the generation of Aβ.
Research has shown that in the brain, most Aβ resides within glycolipid-enriched rafts containing
γ-secretase components.
In AD brains, the composition of lipid rafts has been found to be more ordered and
viscous than in the normal brain. After this discovery, research focused on whether AD could be
prevented by depleting lipid raft components to lower Aβ production [1]. Because 23% of the
body’s total complement cholesterol has been identified as being in the brain, it was the ideal
component to be removed [4]. It was found that depleting cholesterol did in fact reduce APP
induction into lipid rafts lowering Aβ production [1]. Due to this discovery, statins – cholesterol
lowering drugs, have been examined as potential AD fighting drugs. The results have been
conflicting. Some studies have shown that statins have reduced the incidence of AD by lowering
cholesterol levels, while other studies have shown no relation [2]. For obvious reasons, much
more research in this topic needs to be done. It is also proposed that because of the multiple
essential components of lipid rafts, it is likely that eliminating just one would not completely
eradicate Aβ production in vivo [3]. This hypothesis is also supported by a study showing that
cholesterol can either facilitate or inhibit the interaction with Aβ peptides with lipids rafts
depending on the type of glycosphingolipid also found within the raft [1]. It is also worth noting
that cholesterol metabolism in the brain is isolated by the selective permeability of the bloodbrain barrier, thus presenting a challenge in regulating neuronal cholesterol levels
pharmaceutically [3]. Because Aβ oligomers are neurotoxic at nanomolar concentrations, even
miniscule amounts of Aβ could result in AD [1].
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Micellar Electrokinetic Chromatography
Electrophoresis is a technique used to separate molecules by subjection to an electric
differential. The velocity of separation is dependent upon both the size and charge of the
molecules being assessed [6]. Micellar electrokinetic chromatography (MEKC) is a more
recently developed type of electrophoresis that allows for the separation of neutral molecules as
well as those that are charged. In MEKC, lipids are added to the solution in concentrations above
their critical micelle concentrations allowing the formation of micelles. These micelles allow an
analyte to be incorporated in and separated with the same velocity as the micelle [3].
Electroosmotic flow (EOF) is another major component allowing for migration under capillary
electrophoresis (CE) conditions [6]. Due to the negative charge on the inner walls of silica
capillaries, EOF transports the bulk flow of solution toward the negatively charged electrode [3].

Figure 1: Schematic of the separation principle in MEKC [2]

Figure 1 illustrates the separation principle in MEKC [6]. As can be seen, the EOF
moves the bulk flow in the direction of the negatively charged electrode. Depending on the type
of micelles and the conditions of the solution they are in, they can be positively charged,
negatively charged, or have no charge at all. However, because the micelles being used are using
are negatively charged, they move in the direction of the positively charged electrode. When
4

incorporating proteins in the micelles, the charge of the protein changes the velocity with which
the micelles will migrate. A negatively charged protein, as is the case with Aβ, will speed up the
velocity of negatively charged micelle migration by adding to the driving force. A neutrally
charged protein that has incorporated and aggregated into a micelle will neither speed up nor
slow down migration, while a positively charged protein will slow down migration by giving the
analyte conflicting driving forces [3]. If the protein has a very strong positive charge, the charge
along with EOF will actually force the micelle to migrate in the opposite direction [6].
One of the most challenging aspects of studying how Aβ behaves in the brain is creating
an environment similar to the one in vivo. One of the best ways to mimic this environment is to
mix Aβ in a solution of either the long chain lipid 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC) or the short chain lipid 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) Figure 2.
When both lipids are mixed together, a bilayer bicelle structure is formed. When adding these
lipids to electrophoresis, they help to reduce the capillary/analyte interaction [2]. Because of the
efficiency of separation, low sample volumes required, and a quick time of analysis associated
with MEKC, it is an ideal technique to carry out experiments on Aβ [6].

Figure 2: Molecular structures of DHPC (left) and DMPC (right). Courtesy of avantilipids.com.
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Purpose
The ultimate goal of this project is to determine how lipid rafts affect the aggregation
tendencies of Aβ. The rafts will be modeled with DHPC and DMPC micelles. First, Aβ and the
micelles will each be separated alone to determine the best combination of variables for
separation. These will serve as a control for later studies. The Aβ will then be aggregated in the
micelle solutions and separated. The results of these separations will be compared with the
controls to determine the effects that lipid rafts have on the aggregation properties of Aβ.
Materials and Methods
Coating a Capillary
For this study, A Beckman Coulter P/ACE MDQ Glycoprotein System capillary
electrophoresis machine was used to analyze the Aβ and lipids micelles. To reduce protein
interactions with the capillary, when separating Aβ the capillary must be washed and coated with
polyethylene oxide (PEO). This coating also prevents the effect of the EOF. To coat the
capillary, it was first washed with 0.1M NaOH, water, and 0.1M HCl. After being washed, it was
coated with PEO. Table 1 shows the requirements for loading the CE, followed by Table 2
explaining the procedure of the wash and coating.
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Table 1:The loading protocol for the CE to wash and coat a capillary.

Wash
B1

BO

C1:WASTE
C2: WASTE
C3: WASTE

C1: 0.1M NaOH
C2: WATER
C3: 0.1 M HCl
Polymer Coat
B1

BO

B1:WASTE
B2: WASTE
B3: WASTE
B4: WATER

B1: WATER
B2: 0.1 M HCl
B3: 2000 kDa PEO
B4: WATER

Table 2: Specifications of the procedure for a preconditioning wash and polymer coating
Washing
Event
RinsePressure
RinsePressure
RinsePressure
RinsePressure
Coating
Event
RinsePressure
RinsePressure
RinsePressure
RinsePressure
Wait

Value (psi)
50 psi

Duration
(min)
20 min

Vial inlet
side
B1:C1

Vial outlet
side
B0:C1

Pressure
Direction
reverse

Compound
in vial
0.1M NaOH

20 psi

20 min

B1:C2

B0:C2

reverse

Water

20 psi

60 min

B1:C3

BO:C3

reverse

0.1M HCl

20 psi

10 min

B1:C2

B0:C2

reverse

Water

20 psi

Duration
(min)
15 min

Vial inlet
side
B1:B1

Vial outlet
side
B0:B1

Pressure
Direction
reverse

Compound
in vial
Water

20 psi

15 min

B1:B2

B0:B2

reverse

0.1M HCl

50 psi

30 min

B1:B3

BO:B3

reverse

20 psi

15 min

B1:B1

B0:B1

reverse

0.5%
2000kDa
PEO
Water

B1:B4

B1:B4

Value (psi)

Water

7

Buffer Preparation
The buffer used in this study was a 40mM monobasic/dibasic sodium phosphate solution.
The ideal pH for the buffer is 7.4. To achieve this pH, 19mL of monobasic solution was added to
81mL of dibasic solution. To prepare the monobasic solution, 343.22mg of monobasic powder
was dissolved in 22 mL of nanodistilled water. For the dibasic solutions, 1206.66 mg of dibasic
powder was dissolved in 85mL of nanodistilled water. After mixing 19mL of the monobasic and
81mL of the dibasic solutions together, a 100mM buffer was created. This solution was diluted
with 150mL of nanodistilled water to bring the final concentration to 40mM. The pH for this
solution was measured at 7.51. To lower the pH, 1.5mL of the remaining monobasic solution
was added to bring the final buffer pH down to 7.43.
Amyloid Beta Preparation
Aβ1-42 protein was used for this study. Prior to loading the CE with the Aβ, it must first
be diluted in solution. To bring about a basic environment to break up any of the previously
aggregated oligomers, 7.2μL of 5mM NaOH (stored in the 4C fridge) was added to a nonsiliconized micro-centrifuge tube containing 0.0271 mg lyophilized Aβ1-42 ( Anaspec stored in 80°C freezer). The solution was placed in the 4°C fridge for 10 minutes to allow the NaOH to
dissolve the frozen Aβ. After 10 minutes, 142.8 μL of 40mM sodium phosphate buffer was
added to the solution to allow the solution to mimic a more physiological pH. The solution was
then placed back in the fridge for 20 minutes until being loaded into the CE.
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Micelle Solution Preparation
45mM DHPC and DMPC Solutions
Two different lipids were used in this study: DHPC and DMPC. When separating lipids
alone (without Aβ), both lipids were brought to a concentration of 45mM by diluting with 40mM
sodium phosphate buffer. To make the DHPC solution, 20.408mg of DHPC powder was
dissolved in 1.054 mL of buffer. To make the DMPC solution, 30.507mg of DMPC powder was
dissolved in 1.091mL of buffer.
90mM DHPC and DMPC solutions
When separating the lipids and protein together, the initial concentration of the lipid
solutions needed to be 90mM. This concentration will be halved when the protein solution is
added in equal parts. To achieve these concentrations, 40.82 mg of powdered DHPC was
dissolved in 1.019 mL of sodium phosphate buffer, and 61.01 mg of powdered DMPC was
dissolved in 0.958 mL of buffer.
Checking the Buffer
Before running any experiments involving the protein or micelles, the buffer was
separated alone to check for contaminates and proper CE functioning. Table 3 lays out the proper
loading of the CE.
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Table 3: Vial placement in the CE for a buffer checking run

Rinse + Run
B1
A1:WASTE
A2: WASTE
A3: BUFFER
A4: WATER

BO
A1: WATER
A2: BUFFER
A3: BUFFER
A4: BUFFER

The sequence for testing the buffer consisted of two different methods: water buffer rinse
and buffer checking run. Table 4 illustrates the functions of the machine during these two
methods. For all experiments, the CE lamp was set to read at 214nm.
Table 4: Functions of the CE during a water buffer rinse and buffer checking run.

Time

Event
Water Rinse – Pressure
Buffer Rinse – Pressure

Time

Event
Buffer Rinse – Pressure
Buffer Inject – Pressure
Separate – Voltage

0.00

Water Buffer Rinse
Value
Duration Inlet Vial
50.0 psi 10.00 min BI: A1
50.0 psi 10.00 min BI: A2
A2-40buffercheckingrun
Value
Duration Inlet Vial
50.0 psi 5.00 min
BI: A2
0.5 psi
10.00 sec
BI: A4
7.0 KV
10.00 min BI: A3

Outlet Vial
BO: A1
BO: A2

Notes

Outlet Vial
BO: A2
BO: A4
BO: A3

Notes

0.17 Min ramp

If there was ever any drifting in the buffer or an irregular current, troubleshooting was
done. First, the optical components of the CE were cleaned and the buffer was checked again. If
there was still drifting in the graphs, a new buffer was created. When the buffer run went as
expected, the rest of the experiment was completed.
Amyloid Beta Separation
To begin the series of experiments, Aβ was first separated alone. This part of the
experiment was done as a control to be sure of competency of the CE. Due to its tendencies to
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interact with the walls of the capillary, the capillary was always coated when running the protein.
After the Aβ sample was prepared, it was removed from the fridge and gently pipetted up and
down 3 times to ensure a homologous mixture. A microcentrifuge tube was cut at the 0.2 mL line
and 20μL of the Aβ solution was added to the tube. When loading the vial, it is imperative that
no bubbles were in the vial to prevent errors in the CE readings. The remaining Aβ solution was
then placed on the shaker to be aggregated at 25°C and 300RPM. The time of placement on the
shaker was recorded and used at the zero hour time point. Table 5 illustrates the loading of the
CE machine.
Table 5: Vial placement in the CE when running Aβ. The capillary was first rinsed by the buffer. The
sample was then injected into the capillary and separated for 30 minutes in buffer.
Sample Run
B1
BO
A1:WASTE
A1: WATER
A2: WASTE
A2: BUFFER
A3: BUFFER
A3: BUFFER
A4: WASTE
A4: Aβ SAMPLE

Upon starting the run, the lamp energy was recorded. Low lamp energy could give false
readings. The Aβ was separated per Table 6. After the separation was completed, the sample was
wrapped in parafilm and placed back into the -80°C freezer to be saved for further analysis.
Table 6: Sequence completed by the CE for the separation of Amyloid Beta
AB 40um – 30 min sep
Time
Event
Value
Duration Inlet Vial
Buffer Rinse – Pressure
50.0 psi
5.00 min
BI: A2
Sample Inject – Pressure 0.5 psi
10.0 sec
BI: A4
0.00 Separate – Voltage
7.0 KV
30.00 min BI: A3

Outlet Vial
BO: A2
BO: A4
BO: A3

Notes

0.17 min ramp

At the conclusion of each time point, a final wash was completed per Table 7.
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Table 7: the final end wash method used at the completion of each experiment. This method rinsed the
capillary and turned off the fluorescent lamp
Time

Event
Lamp – Off
Water Rinse – Pressure
Wait

Value
50.0 psi

Final End Wash
Duration Inlet Vial
10.00 min
1.00 min

BI: A1
BI: A4

Outlet Vial

Notes

BO: A1
BO: A4

The capillary was prewashed using the water buffer rinse in Table 4 30 minutes prior to
each run. Three hours from when the vial was placed on the shaker, it was removed from the
shaker, mixed, and loaded into the CE in the same manner as the zero hour time point. The
remaining sample was then placed back on the shaker to aggregate for four more hours. Upon
completion of the three hour time point separation, the sample that was ran was wrapped in
parafilm and placed in the -80°C freezer. The seven hour time point was repeated analogously to
the zero and three hour time points. Upon completion of the seven hour time point, the results
were saved for further analysis.
Micelle Separation
After preparing the micelle solutions, they were stored in the -20°C freezer. The micelles
were allowed to thaw out at room temperature until they were completely liquefied. Like the
protein, they were gently pipetted up and down three times to ensure a homologous mixture.
DHPC was the first micelle tested. A microcentrifuge tube was cut at the 0.2 mL line and 20 μL
of the DHPC solution was pipetted into the tube. It is imperative to avoid having bubble in the
sample as it will create an unwanted spike on the CE reading. This was repeated for the DMPC
solution. The CE was loaded per Table 8 for the separation sequence.
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Table 8: The proper loading of the CE in preparation for the DHPC and DMPC separation.
Micelle Separation
BI
A1:WASTE
A2: WASTE
A3: BUFFER
A4: WASTE
A5: WASTE

BI
A1: WATER
A2: BUFFER
A3: BUFFER
A4: DHPC
A5: DMPC

The separation sequence was a five part sequence. First a water buffer rinse (Table 4) was
done to be sure the capillary was cleaned and ready. The separation of DHPC followed – the
method can be seen in Table 9. The capillary was then cleaned again with a water buffer rinse
(Table 4) prior to the DMPC separation. The method for this separation can be seen in Table 10.
A final end wash was then done to clean the capillary and turn the lamp off (Table7). The DHPC
and DMPC solution were run twice in a coated capillary in normal polarity and twice with an
uncoated capillary in reverse polarity. In normal polarity, EOF moves the bulk flow toward the
negatively charged cathode. The proteins and micelles migrate against the EOF through the
detection window toward the positively charged anode. In reverse polarity, the EOF is partially
suppressed and the window of detection is closest to the positively charged anode.
Table 9: Separation sequence for DHPC
DHPC 45um – 10 Min. Separation – Normal (or reverse) Polarity
Time
Event
Value
Duration Inlet Vial Outlet Vial
Notes
Rinse – Pressure
50.0 psi 5.00 min
BI: A2
BO: A2
Buffer
Inject – Pressure
0.5 psi
6.0 sec
BI: A4
BO: A4
DHPC Sample
0.00 Separate – Voltage 7.0 KV
10.00 min BI: A3
BO: A3
0.17 min ramp,

Table 10: Separation Sequence for DMPC
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DMPC 45um – 10 Min. Separation – Normal (or reverse) Polarity
Time
Event
Value
Duration Inlet Vial Outlet Vial
Notes
Rinse – Pressure
50.0 psi 5.00 min
BI: A2
BO: A2
Buffer
Inject – Pressure
0.5 psi
6.0 sec
BI: A4
BO: A4
DMPC Sample
0.00 Separate – Voltage 7.0 KV
10.00 min BI: A3
BO: A3
0.17 min ramp,

Micelle + Amyloid Beta Separation
Two different tests where run with the micelles mixed with Aβ. Both tests were
analogous in the sequence to the micelles being run alone. The first test consisted of separating
DHPC with Aβ and DMPC with Aβ. To create the micelle/Aβ solution, the 90mM micelle
solution was used with a previously mixed 60mM Aβ solution. The micelle solutions were
removed from the -20°C fridge and allowed to thaw while the Aβ was removed from the -80C
freezer. To make the Aβ/micelle mixture, 18μL of each solution micelle solution was pipetted
into its own microcentrifuge tube, followed by 18μL of Aβ. The solutions were gently pipetted
up and down to ensure a homologous mixture and 20μL of each solution was then added to a
precut microcentrifuge tube and loaded into the CE in the same way as the micelles alone. The
same five step process was then used to separate the mixtures with the exception of increasing
the separation time to 30 minutes. This test was completed once with a coated capillary in
normal polarity and once with a coated capillary in reverse polarity. The results of the
experiment were saved for further analysis.
Results and Discussion
Amyloid Beta – Coated Capillary – Normal Polarity
Aβ peptides have a strong tendency to aggregate and are very “sticky”. Because of this,
when running an Aβ separation, the silica capillary was coated with PEO. The PEO coating
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helped to prevent the Aβ from attaching to the sides of the capillary. It also helped to eliminate
EOF during separation. The Aβ was separated with a normal polarity to move the micelles
toward the positive anode. Before completing any separation involving the proteins, buffer was
separated alone to check for imperfections in the buffer and the correct operation of the CE.
Figure 3 shows the absorbance expected when running buffer alone. Because there are no
analytes in the buffer alone to separate, there should be no peaks.

30
25

UV214nm

20
15
10
5

Current, μA

Absorbance,Au

Buffer - Coated - Normal Polarity
0.001
0.0005
0
-0.0005
-0.001
-0.0015
-0.002
-0.0025
-0.003

0

-5
0

2

4
6
Time [min]

8

10

Figure 3: MEKC negative control of sodium phosphate buffer only showing no contaminant peaks
present. Coated 31 cm capillary run with normal polarity at 7.0 kV with UV detection at 214 nm.

After completing the negative control (buffer only) and confirming that no contaminants
were present, the capillary was washed and aggregated Aβ was separated. When separating
aggregated proteins, the larger oligomer species migrate first because of a larger surface charge.
Figure 4 illustrates the absorbance readings when separating Aβ in a buffer solution. The
baseline was removed to allow for a better visualization of the peaks produced. The peaks
represent monomers or oligomers as they pass through the absorbance window. The first peak is
the smallest at the zero hour time point and gets larger as aggregation time increases. This
indicates that there are more of the larger oligomer species after extended aggregation. The later
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peak decreases in size with increasing aggregation times, illustrating that there are less of the
smaller molecules with extended aggregation. From these results, it can be concluded that the
smaller oligomers or even monomers aggregate over time to become a higher ordered oligomer.
This experiment was repeated two more times giving analogous results. These results will be
used as a control when separating Aβ in a micelle solution.

Amyloid Beta - Coated - Normal Polarity
3.00E-02

Abosrbacne 214nm

2.50E-02
2.00E-02
1.50E-02

0 Hours

1.00E-02

3 Hour
7 Hour

5.00E-03
0.00E+00
0
-5.00E-03

5

10

15

20

Time [min]

Figure 4: MEKC separation of Aβ in sodium phosphate buffer at 7.0 kV in a coated 31.0 cm

capillary at normal polarity with UV detection at 214 nm. Shown are the 0, 3, and 7 hour
aggregation time points. Baselines have been subtracted for a cleaner representation.
DHPC and DMPC - Coated Capillary – Normal Polarity
The next phase of the study consisted of analyzing micelles alone in a way analogous to
the Aβ alone. The capillary was coated and the lipids were separated in normal polarity. Figure 5
and Figure 6 show the result of this separation for DHPC and DMPC. As expected, the micelles
did not migrate in the same way as the Aβ. Because of the weak negative charge of the micelles,
there was not enough electrical driving force to overcome the EOF. Therefore, the micelles
migrated away from the detection window.
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DHPC - Coated - Normal Polarity
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Figure 5: MEKC separation of DHPC in sodium phosphate buffer at 7.0 kV in a coated 31.0 cm
capillary. Run with normal polarity at 214 nm UV detection
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Figure 6: MEKC separation of DMPC in sodium phosphate buffer at 7.0 kV in a coated 31.0 cm
capillary. Run with normal polarity at 214 nm UV detection.

DHPC and DMPC – Uncoated Capillary – Reverse Polarity
The DHPC and DMPC micelles were then analyzed in an uncoated capillary in reverse
polarity. The results from this separation were markedly different that those with from the
previous phase of the study. As can be seen in Figure 7 and Figure 8 the micelle solutions
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migrated quickly and at similar times. These results were expected. By leaving the capillary
uncoated, the EOF was a much stronger factor in the migration of the analytes. Because of the
weak charge of the micelles, this was the only force driving their separation. This experiment
was also repeated three times with analogous results. Thus it was concluded that micelles of

DHPC - Uncoated - Reverse Polarity
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DHPC and DMPC could be detected by MEKC in a sodium phosphate buffer.
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Figure 7: MEKC separation of DHPC in sodium phosphate buffer at 7.0 kV in an uncoated 31.0 cm
capillary. Run with reverse polarity at 214 nm UV detection.
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Figure 8: MEKC separation of DMPC in sodium phosphate buffer at 7.0 kV in an uncoated 31.0 cm
capillary. Run with reverse polarity at 214 nm UV detection. There was an issue with the current in this
run, however it was following the micelle separation thus did not affect the outcome.
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DHPC + Aβ and DMPC + Aβ – Coated Capillary – Normal Polarity
After testing the micelles and Aβ separately using MEKC, tests could be conducted with
a mixture of both micelles and Aβ. Aβ that had previously been aggregated for three hours was
mixed with a micelle solution and separated. Figure 9 and Figure 10 show the results of this
separation. As these figures show, there was no significant detection of peaks. This is most likely
due to the micelles slowing down the migration of Aβ, thus a longer detection time would be
required.
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Figure 9: MEKC separation of DHPC + Aβ in sodium phosphate buffer at 7.0 kV in a coated 31.0 cm
capillary. Run with normal polarity at 214 nm UV detection.
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Figure 10: MEKC separation of DHPC + Aβ in sodium phosphate buffer at 7.0 kV in a coated 31.0 cm
capillary. Run with normal polarity at 214 nm UV detection.

Conclusion & Future Work
Unfortunately, due to CE failures, power outages, and difficulty getting supplies, this
study was not was conclusive as originally anticipated. However, some good results were still
obtained to be used as controls and for future studies. The Aβ proteins were separated on three
different runs, each showing analogous results. For each run, at the zero hour time point, there
were more of the smaller oligomer species than the larger ones. At the three and seven hour time
points, the number of smaller species decreased, causing the increase in the larger species. Thus,
the Aβ aggregation protocol used in this study is a successful one that can be repeated in the
future. It was also determined that micelles separate most efficiently in an uncoated capillary in
reverse polarity. They however did not migrate in any analytically beneficial way when
separated in a coated capillary in normal polarity. This is due to the lack of charge and the
coating removing the EOF factor of migration. When separating the Aβ in a micelle solution,
hope was given for future studies as small peaks of possible aggregation were observed when the
solutions were separated in an uncoated capillary in normal polarity.
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Though majorly inconclusive, this experiment sets a solid foundation for future
experimentation. First, further runs need to be completed mixing the Aβ protein with the micelle
solutions. The variable of capillary coating and direction of polarity need to be altered and
analyzed to determine the most effective way of achieving analytically beneficial results when
separating Aβ in a micelle solution. Once the optimal combination has been determined, the
main purpose of the experiment will be ready to be tested. The Aβ will need to be dissolved in
the micelle solution prior to aggregation. Time points throughout aggregation will then be set
and samples will be separated at those time points. Once this part of the study is concluded,
hopefully it will be clear how the micelle solutions affect the aggregation properties of Aβ. With
this knowledge hopefully we as a medical community will be one step closer to preventing the
onset of one of the most devastating diseases in modern medicine.
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